Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Claudio Martines"'
Autor:
Supriya Chakraborty, Giulia Felician, Claudio Martines, Alice Bonato, Ana Colado, Marija Vujovic, Aleksandar J. Dimovski, Dimitar G Efremov
Publikováno v:
Blood. 140:1536-1537
Autor:
Claudio Martines, Supriya Chakraborty, Marija Vujovikj, Stefania Gobessi, Tiziana Vaisitti, Silvia Deaglio, Luca Laurenti, Aleksandar J. Dimovski, Dimitar G. Efremov
A large amount of circumstantial evidence has accumulated suggesting that Toll-like receptor (TLR) signals are involved in driving chronic lymphocytic leukemia (CLL) cell proliferation, but direct in vivo evidence for this is still lacking. We have n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d7cbbdbd7f254ae6218a0dd14a8513c
https://hdl.handle.net/2318/1887765
https://hdl.handle.net/2318/1887765
Autor:
D. Piffaretti, Franco Cavalli, V. Gattei, Tamara Bittolo, Michael Gregor, Jakob Passweg, Jui Wan Loh, Claudio Martines, Adalgisa Condoluci, Lorenzo De Paoli, Hossein Khiabanian, Antonella Zucchetto, Georg Stussi, Clara Deambrogi, Paolo Ghia, Lydia Scarfò, M. Faderl, Erika Tissino, L. Terzi di Bergamo, Bernhard Gerber, Emanuele Zucca, Amartya Singh, Ricardo Koch, Gianluca Gaidano, Francesco Autore, Davide Rossi, Francesco Passamonti, Silke Gillessen, Dimitar G. Efremov, Riccardo Moia, Silvia Rasi, Alessandra Tedeschi, K. Pini, Anna Maria Frustaci, Michele Merli, Wei Wu, Gabriela Forestieri, Valeria Spina, Marco Montillo, Luca Laurenti, Alessio Bruscaggin
Publikováno v:
Hematological Oncology. 39
Autor:
Wei Wu, Dimitar G. Efremov, M. Faderl, Silke Gillessen, Deborah Piffaretti, Silvia Rasi, Georg Stussi, Lorenzo De Paoli, Michele Merli, K. Pini, Ricardo Koch, Francesco Passamonti, Hossein Khiabanian, Anna Maria Frustaci, Alessio Bruscaggin, Michael Gregor, Claudio Martines, Davide Rossi, Lydia Scarfò, Bernhard Gerber, Clara Deambrogi, Lodovico Terzi di Bergamo, Amartya Singh, Alessandra Tedeschi, Marco Montillo, Antonella Zucchetto, Gabriela Forestieri, Valeria Spina, Luca Laurenti, Franco Cavalli, Jakob Passweg, Adalgisa Condoluci, Riccardo Moia, Paolo Ghia, Jui Wan Loh, Gianluca Gaidano, Erika Tissino, Valter Gattei, Tamara Bittolo, Francesco Autore, Emanuele Zucca
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S323-S324
Context: Ibrutinib inhibits BTK with the most typical response in CLL being partial remission (PR) with measurable minimal residual disease (MRD) in blood. Remission is usually maintained until development of genetically-driven resistance. Objective:
Autor:
Dimitar G. Efremov, Silvano Piazza, Supriya Chakraborty, Tiziana Vaisitti, Alice Bonato, Marija Dimishkovska, Silvia Deaglio, Rosa Fazio, Fabiola Porro, Idanna Innocenti, Ilaria Fortunati, Aleksandar Dimovski, Luca Laurenti, Alberto Zamò, Claudio Martines, Brijesh Singh Yadav
Publikováno v:
Blood. 138(12)
B-cell receptor (BCR) signals play a critical role in the pathogenesis of chronic lymphocytic leukemia (CLL), but their role in regulating CLL cell proliferation has still not been firmly established. Unlike normal B cells, CLL cells do not prolifera
Autor:
Ilaria Fortunati, Idanna Innocenti, Silvia Deaglio, Alberto Zamò, Aleksandar Dimovski, Rosa Fazio, Dimitar G. Efremov, Brijesh Singh Yadav, Marija Dimishkovska, Supriya Chakraborty, Tizianna Vaisitti, Luca Laurenti, Alice Bonato, Fabiola Porro, Claudio Martines
B cell receptor (BCR) signals play a critical role in the pathogenesis of chronic lymphocytic leukemia (CLL), but their role in regulating CLL cell proliferation has still not been firmly established. Unlike normal B cells, CLL cells do not prolifera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366b33d84002704d943fe86c2ca158d8
http://hdl.handle.net/10807/184877
http://hdl.handle.net/10807/184877
Autor:
Oleg Vsevolodovich Gerasimenko, Julia Vladimirovna Gerasimenko, Monika A. Jakubowska, Martijn Kerkhofs, Claudio Martines, Pawel E. Ferdek, Ole H. Petersen, Tim Vervliet, Dimitar G. Efremov, Geert Bultynck
Publikováno v:
British Journal of Pharmacology
BACKGROUND AND PURPOSE: Many cancer cells depend on anti-apoptotic B-cell lymphoma 2 (Bcl-2) proteins for their survival. Bcl-2 antagonism through Bcl-2 homology 3 (BH3) mimetics has emerged as a novel anti-cancer therapy. ABT-199 (Venetoclax), a rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2401c37419919bf429a83c0508e79a6d
https://lirias.kuleuven.be/handle/123456789/628186
https://lirias.kuleuven.be/handle/123456789/628186
Autor:
Lodovico Terzi di Bergamo, Gabriela Forestieri, Jui Wan Loh, Amartya Singh, Valeria Spina, Antonella Zucchetto, Adalgisa Condoluci, Martin Faderl, Ricardo Koch, Alessio Bruscaggin, Katia Pini, Wei Wu, Deborah Piffaretti, Tamara Bittolo, Erika Tissino, Lorenzo De Paoli, Clara Deambrogi, Anna Maria Frustaci, Francesco Autore, Michele Merli, Lydia Scarfò, Silvia Rasi, Jakob Passweg, Riccardo Moia, Claudio Martines, Paolo Ghia, Franco Cavalli, Emanuele Zucca, Bernhard Gerber, Silke Gillessen, Georg Stüssi, Marco Montillo, Francesco Passamonti, Michael Gregor, Luca Laurenti, Alessandra Tedeschi, Gianluca Gaidano, Dimitar Efremov, Valter Gattei, Hossein Khiabanian, Davide Rossi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S221
Autor:
Katsuhiko Mikoshiba, Luca Laurenti, Claudio Martines, Rita La Rovere, Paolo Pinton, Jan B. Parys, Haidar Akl, Mart Bittremieux, Ann Janssens, Peter Vandenberghe, Dimitar G. Efremov, Kathia Dubron, Geert Bultynck, Kirsten Welkenhuyzen, Giampaolo Morciano, Humbert De Smedt, Myriam Baes, Katja Rietdorf, Martin D. Bootman
Publikováno v:
Cell Death and Differentiation
Anti-apoptotic Bcl-2 proteins are upregulated in different cancers, including diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL), enabling survival by inhibiting pro-apoptotic Bcl-2-family members and inositol 1,4,5-trisphos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d38ef1fce412300a631446e3a65cc47
Autor:
Claudio Martines, Malgorzata Bobrowicz, Sven Turkalj, Beata Pyrzynska, Joanna Stachura, Binu K. Sasi, Engin Bojnik, Francesco Bertoni, Dimitar G. Efremov, Magdalena Winiarska, Richard Rosenquist, Elena Xerxa, Hilal Kalkan, Larry Mansouri, Valdemar Priebe, Fabiola Porro, Rosa Fazio, Abdessamad Zerrouqi
Publikováno v:
Leukemia. 33(10)
The BCL-2 inhibitor venetoclax has only limited activity in DLBCL despite frequent BCL-2 overexpression. Since constitutive activation of the B cell receptor (BCR) pathway has been reported in both ABC and GCB DLBCL, we investigated whether targeting